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Objective: This study examined the effects of a short-term reduction in physical
activity, and subsequent resumption, on metabolic profiles, body composition and
cardiovascular (endothelial) function.
Design: Twenty-eight habitually active (≥10,000 steps/day) participants (18 female, 10
male; age 32 ± 11 years; BMI 24.3 ± 2.5 kg/m2) were assessed at baseline, following
14 days of step-reduction and 14 days after resuming habitual activity.
Methods: Physical activity was monitored throughout (SenseWear Armband).
Endothelial function (flow mediated dilation; FMD), cardiorespiratory fitness (V̇O2
peak) and body composition including liver fat (dual-energy x-ray absorptiometry and
magnetic resonance spectroscopy) were determined at each assessment. Statistical
analysis was performed using one-way within subject’s ANOVA; data presented
as mean (95% CI).
Results: Participants decreased their step count from baseline by 10,111 steps/day
(8949, 11,274; P < 0.001), increasing sedentary time by 103 min/day (29, 177;
P < 0.001). Following 14 days of step-reduction, endothelial function was reduced
by a 1.8% (0.4, 3.3; P = 0.01) decrease in FMD. Following resumption of habitual
activity, FMD increased by 1.4%, comparable to the baseline level 0.4% (–1.8, 2.6;
P = 1.00). Total body fat, waist circumference, liver fat, whole body insulin sensitivity and
cardiorespiratory fitness were all adversely affected by 14 days step-reduction (P < 0.05)
but returned to baseline levels following resumption of activity.
Conclusion: This data shows for the first time that whilst a decline in endothelial
function is observed following short-term physical inactivity, this is reversed on
resumption of habitual activity. The findings highlight the need for public health
interventions that focus on minimizing time spent in sedentary behavior.
Keywords: cardiorespiratory fitness, endothelial function, insulin resistance, liver fat, physical activity, sedentary
behavior
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INTRODUCTION
Epidemiological evidence demonstrates that physical inactivity
(defined as physical activity too low to meet physical activity
guidelines) and sedentary behavior (defined as any waking
behavior characterized by an energy expenditure < 1.5 metabolic
equivalents (METS), while in a sitting, reclining or lying posture)
play a role in the development of obesity, insulin resistance,
type 2 diabetes and cardiovascular disease (CVD) (Lee et al.,
2012; Henson et al., 2013; Smith et al., 2016; Tremblay et al.,
2017). However, such evidence provides no mechanistic insight
into the underlying pathophysiological changes associated with
these behavior profiles. Whilst we understand that a physically
active lifestyle is protective against CVD (Paffenbarger et al.,
2001), the specific cardiovascular consequences of physical
inactivity and/or increased sedentary time have not been
comprehensively evaluated.
Mechanistic studies of reduced physical activity in humans
have used extreme experimental models including prolonged
bed rest (Alibegovic et al., 2010), limb immobilization (Abadi
et al., 2009), and complete cessation of exercise in exercise-
trained volunteers (King et al., 1988). These models are not
physiologically representative of habitual activity levels in free-
living individuals and must therefore be interpreted with
caution. More recently, an alternative experimental model has
been adopted in which physically active (∼10,000 steps/day)
volunteers, who do not participate in regular exercise, transition
to an inactive lifestyle (reducing to ∼1500 steps/day) for brief
periods (∼14 days) (reviewed in Bowden Davies et al., 2019).
This approach reflects societal changes in physical activity
levels (i.e., reduced physical activity and more sedentary time)
promoted by occupational changes and technological advances
(Church et al., 2011; Althoff et al., 2017). Step-reduction models
have clearly demonstrated that reduced physical activity is
associated with detrimental physiological changes, including
reduced cardiorespiratory fitness, accumulation of central fat,
loss of skeletal muscle mass with associated anabolic resistance,
and reduced peripheral insulin sensitivity (Olsen et al., 2008;
Krogh-Madsen et al., 2010; Knudsen et al., 2012; Breen et al.,
2013; McGlory et al., 2017; Bowden Davies et al., 2018).
Endothelial function, an early prognostic and reversible marker
of CVD, has been studied when transitioning individuals to
∼5000 steps/day for 5 days (Boyle et al., 2013; Restaino et al.,
2016; Teixeira et al., 2017). Endothelial function was reduced
but any changes on resumption of usual physical activity has not
been studied. The endothelium plays a pivotal role in vascular
homeostasis (Furchgott and Zawadzki, 1980), and brachial artery
flow-mediated dilation (FMD) has been shown to be predictive of
future CVD risk (Green et al., 2011).
We evaluated endothelial function in a specific subset of
individuals from our previously published step-reduction cohort
(Bowden Davies et al., 2018), and present for the first time
changes in endothelial function following a 14 day reduction
to ∼1,500 steps/day with subsequent resumption to usual
activity. The primary aim of this study was to investigate
the cardiovascular-specific consequences of 14-days decreased
physical activity with increased sedentary behavior in free-living
individuals, hypothesizing that endothelial function would
decline but return to baseline after a following 14-day activity
resumption. Other markers of physical health are reported to




A mean daily step count ≥10,000 was required for participants to
be eligible. Physical activity screening was blinded and consisted
of monitoring from midnight to midnight on 4 consecutive
days, including 1 weekend day (accelerometer details below).
If eligible, participants underwent their initial assessment visits
before being instructed to reduce their activity to ∼1500 steps
for 14 days after which the assessments were repeated. The
reduction to 1500 steps/day was based on methodology from
previously reviewed studies (Bowden Davies et al., 2019) and
unpublished data from our group that has assessed the habitual
activity of patients with type 2 diabetes. Habitual activity was
then resumed for a further 14 days before participants underwent
their final assessment visits. There were two assessment visits at
each time point: (1) at Liverpool University Hospitals (Aintree
site) for anthropometry, flow mediated dilation (FMD), fasting
biochemistry, oral glucose tolerance test (OGTT) and V̇O2
peak; and (2) at the University of Liverpool for dual-energy
x-ray absorptiometry (DXA) and proton magnetic resonance
spectroscopy (1H-MRS).
The study took place between December 2014 and August
2017, and 28 participants successfully completed the intervention
with all measures available. Dietary records were taken in the
4 days preceding an assessment visit; participants were instructed
to maintain their usual dietary habits throughout the study.
Participants
Habitually active participants with no history/current
engagement in regular structured exercise (>2 h/week) or
highly physical employment (determined by questionnaire)
were recruited from local advertisements across hospital
departments and university campuses. Exclusions included:
cardiovascular, respiratory, kidney, liver, and/or endocrine
complications, smokers and those consuming > 14 units/week of
alcohol consumption. The study conformed to the Declaration of
Helsinki and was approved North West – Liverpool Central ethics
committee (14/NW/1147 and 14/NW/1145). All participants
were informed of the methods verbally and in writing before
providing written informed consent prior to any assessments.
Before each visit, participants were required to fast overnight for
>8 h, abstain from alcohol and caffeine for 24 h and from any
formal exercise for 48 h.
Experimental Measures
Anthropometric Measurements
Weight, height (to the nearest 0.5 cm) using a stadiometer (Model
220, Seca, Germany), and waist (umbilicus) and hip (greater
trochanter) circumferences, were measured in duplicate (retested
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if not within 5 mm). Participants then rested for 5 min before BP
was determined from an average of three measures (Dinamap,
G&E Medical, United States).
Biochemical Measurements
Blood samples were collected and analyzed using the Olympus
AU2700 analyzer (Beckman Coulter, High Wycombe,
United Kingdom) with standard proprietary reagents as
follows: glucose with hexokinase, total cholesterol and HDL-
cholesterol with cholesterol esterase/oxidase and triacylglycerol
with glycerol kinase. LDL-cholesterol was calculated according
to the Friedewald formula. Insulin was measured using
radioimmunoassay (Invitrogen, Paisley, United Kingdom).
HOMA-IR was calculated using fasting glucose and insulin
concentrations (Matthews et al., 1985). The intra- and inter-assay
coefficient of variation for all blood parameters was ≤5%.
Oral Glucose Tolerance Test
After fasting blood samples were collected, a 75 g glucose
solution was consumed within 5 min and post-ingestion blood
samples were drawn at 30–, 60-, 90-, and 120-min. Glucose,
insulin and NEFA responses were calculated as AUC. Matsuda
index was calculated to estimate whole-body insulin sensitivity
(Matsuda and DeFronzo, 1999).
Cardiorespiratory Fitness
A V̇O2 peak cardiopulmonary exercise test (CPET) was
performed on a treadmill (Model 77OCE, RAM Medisoft Group,
Manchester, United Kingdom) in a temperature-controlled
room. The CPET provided breath-by-breath monitoring
and analysis of expiratory gases and ventilation as well as
continuous electrocardiographic monitoring (Love Medical
Cardiopulmonary Diagnostics, Manchester, United Kingdom).
The modified Bruce protocol was employed: after an initial 2 min
warm up at 2.2 km/h on a flat gradient, stepwise increments
in speed and gradient were made each min. V̇O2 peak was
determined by any two of: respiratory exchange ratio > 1.15;
heart rate > 90% predicted maximum; plateau in V̇O2; or
exhaustion. V̇O2 peak data were expressed in three ways:
absolute (l/min), relative to total body mass (ml min−1 kg−1),
and relative to lean body mass (ml min−1 kg−1; termed
‘V̇O2 peak lean’).
Physical Activity Monitoring
Physical activity was tracked throughout using a SenseWear
mini armband (BodyMedia, Pittsburgh, PA, United States).
Instructions were that the armband was to be worn at all possible
times, and the inclusion criterion was >90% wear time, which
was monitored using SenseWear Professional software (version
8.0). Data collected from the armband included: daily average
step count; total energy expenditure; active energy expenditure;
and time spent in domains of physical activity, including sleep,
lying, sedentary (<1.5 METS), light (1.5–3 METS), moderate (3–
6 METS), vigorous (6–9 METS), and very vigorous (>9 METS).
Dietary Analysis
Total energy consumption, carbohydrate, protein, and fat
content were determined from dietary records by a registered
nutritionist (KLM) using Nutritics (Nutrition Analysis Software
for Professionals1; accessed 17/07/2017).
Dual-Energy X-Ray Absorptiometry
Whole-body scans were performed in line with manufacturer’s
guidelines using Lunar iDXA (GE Healthcare, Amersham,
United Kingdom), and were analyzed using the instrument’s
software (version 13.60.033) to determine body fat, lean body
mass and bone mineral density. Each scan session was preceded
by a calibration routine, using multiple quality-control phantoms
that simulate soft tissue and bone.
1H-MRS
Liver and skeletal muscle fat were determined using a 1.5 T
Siemens Symphony MRI scanner (Siemens Medical Solutions,
Erlangen, Germany) as previously described (Cuthbertson et al.,
2012; Jones et al., 2012; Cuthbertson et al., 2016). In brief,
intrahepatocellular lipid (IHCL; liver fat) is expressed as the
percentage of CH2 lipid signal amplitude relative to water signal
amplitude and intramyocellular lipid (IMCL; skeletal muscle
lipid) is expressed as CH2 lipid amplitude relative to total
creatine amplitude.
Brachial Artery Flow Mediated Dilation (FMD)
Endothelial function was assessed by measuring FMD in response
to a 5 min ischemic stimulus, induced by inflation of a forearm
cuff placed immediately distal to the olecranon process, as
previously described (Sprung et al., 2014) and in line with
expert recommendations (Thijssen et al., 2019). Briefly, baseline
images were recorded for 1 min prior to forearm cuff inflation
(∼220 mmHg) for 5 min. Artery diameter and blood flow
velocity recordings resumed 30 s prior to cuff deflation and
continued for 3 min thereafter. Peak brachial artery diameter
and blood flow velocity, and the time taken to reach these
peaks following cuff release were recorded. Post-test analysis of
brachial artery diameter was undertaken using custom-designed
automated edge-detection and wall-tracking software.
Sample Size Calculation
The primary outcome variable was change in FMD. Previous
studies have examined vascular function following 5 days of
physical inactivity (Boyle et al., 2013) and detected differences
in popliteal but not brachial artery FMD. However, given the
increased longevity of our intervention (14 days as opposed to 5),
and more profound reduction in physical activity (reduction to
from >10,000 steps to 1,500 steps per day rather than 5,000), we
would expect a detrimental effect on FMD systemically (in upper
limbs as well as lower). Using a paired t-test with a 0.05 two-sided
significance level, a sample size of 26 would have 90% power to
detect a difference in means of 1.2%, assuming that the standard
deviation in change score for both groups is 1.5 (G∗Power 3.1.5).
Statistical Analysis
Statistical analysis was performed using SPSS for Windows
(Version 24.0, SPSS, Chicago, IL, United States). All continuous
data were explored for normality using visual inspection of
1https://www.nutritics.com/p/home
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frequency distribution, and logarithmically transformed where
appropriate. Data were back transformed to original units for
reporting. The outcome variables (e.g., FMD) were analyzed
using a repeated measures ANOVA. Statistically significant main
effects were further explored through pairwise comparisons
between timepoints with the Bonferroni approach to multiple
testing. All FMD data were analyzed, and are presented, following
allometric scaling which uses baseline artery diameter measured
prior to the introduction of hyperemia in each test as a
covariate; this approach is more accurate for scaling changes in
artery diameter than simple percentage change (Atkinson and
Batterham, 2013; Atkinson et al., 2013). Distribution data are
presented as mean ± SD and outcomes of ANOVA as mean (95%
CI). The alpha level of statistical significance was set at P < 0.05.
RESULTS
Baseline Characteristics
Twenty-eight habitually active participants (18 female, 10 male;
age 32 ± 11 years; BMI 24 ± 2.4 kg/m2) successfully completed
the intervention with all measures; baseline characteristics are
shown in Table 1.
Changes in Pattern of Physical Activity
Daily step count decreased from baseline during step-reduction
by 10,111 steps/day (8949, 11,274; Figure 1A) increasing waking
sedentary time by 103 min/day (29, 177; Figure 1C). Full
physical activity data is shown in Figure 1; all intensities of
activity > 3 METS decreased significantly during step-reduction.
There were no significant differences in any physical activity
measures between baseline and following resumption of activity,
showing that habitual physical activity levels were successfully
restored and sedentary time comparable to baseline (P > 0.05).
Dietary Analysis
Total energy consumption did not change throughout the
intervention (P > 0.05). Specifically, macronutrient percentages
were 56 ± 15% carbohydrate, 24 ± 10% protein, and 20 ± 9% fat.
Total energy consumption (KJ), carbohydrates (g), protein (g),
and fat (g) are provided in Supplementary Table 1.
Clinical Characteristics
Body mass, BMI and waist: hip ratio did not change during the
intervention (P = 0.240, P = 0.263, and P = 0.491, respectively)
whereas waist circumference increased by 0.8 cm (0.3, 1.3;
P = 0.002) after step-reduction. Systolic BP and diastolic BP
remained unchanged during the intervention (P = 0.904 and
P = 0.914, respectively).
Brachial Artery Flow Mediated Dilation
(FMD)
A significant effect of physical activity was identified (P = 0.04;
Figure 2A). Post hoc comparisons revealed that FMD decreased
by 1.8% (0.4, 3.3; P = 0.01) following 14 days of step-
reduction, then increased by 1.4% (–0.03, 3.1; P = 0.15) following
resumption of habitual activity to a value similar to that observed
at baseline, the overall change being 0.4% (–1.8, 2.6; P = 1.00).
All vascular function data is summarized in Table 2. There
was no significant overall effect of physical activity on baseline
(P = 0.07) or peak diameter (P = 0.07). Upon resumption
of habitual activity, structural properties of the artery were
comparable to baseline [baseline 0.01 mm (0.00, 0.02); P = 0.49;
peak 0.01 (0.00, 0.01); P = 0.42]. There was no effect of physical
inactivity on sheer rate AUC (P = 0.86) or time to peak dilation
(P = 0.42).
Cardiorespiratory Fitness
V̇O2 peak relative to body mass decreased following step-
reduction by 2.6 kg/ml/min (0.5, 4.8; P = 0.012; Figure 2B).
TABLE 1 | Participant characteristics at baseline.
Characteristic Mean ± SD
Clinical
Age (years) 32 ± 11
Body mass (kg) 71.5 ± 9.7
BMI (kg m−2) 24.0 ± 2.4
Waist circumference (cm) 86 ± 8
Hip circumference (cm) 98 ± 6
Waist: hip ratio 0.9 ± 0.1
SBP (mmHg) 119 ± 14
DBP (mmHg) 73 ± 8
Glucose regulation
Whole-body IS (Matsuda index)a 3.4 ± 1.7
HOMA-IR 3.8 ± 1.9
Lipid profile
Cholesterol (mmol/l) 4.9 ± 0.9
Triglyceride (mmol/l)a 0.9 ± 0.6
HDL-cholesterol (mmol/l) 1.9 ± 0.5
LDL-cholesterol (mmol/l) 2.6 ± 0.9
Cholesterol:HDL-cholesterol ratio 2.7 ± 0.8
Body composition
Total body fat (%) 29.6 ± 8.7
Android fat (%) 30.0 ± 10.3
Gynoid fat (%) 33.1 ± 10.7
Total lean mass (kg) 48.2 ± 9.2
Leg lean mass (kg) 16.9 ± 3.3
Arm lean mass (kg) 5.4 ± 1.7
IHCL (%)a 0.6 ± 0.6
IMCL (%) 7.2 ± 4.1
Cardiorespiratory fitness and physical activity
V̇O2 (l min−1) 2.6 ± 0.5
V̇O2 peak (ml min−1 kg−1) 36.1 ± 6.1
V̇O2 peak lean (ml min−1 kg−1) 53.3 ± 5.0
Daily total energy expenditure (kJ day −1)a 11739 ± 2912
Daily steps (steps)a 12624 ± 2064
Daily total sedentary time (min) 998 ± 112
Daily waking sedentary time (min) 597 ± 94
Daily light activity (min) 224 ± 67
Daily moderate-vigorous activity (min)a 165 ± 86
aVariables analyzed following logarithmic transformation.
IR, insulin resistance; IS, insulin sensitivity; IHCL, intrahepatocellular lipid (liver fat);
IMCL, intramyocellular lipid (skeletal muscle lipid).
Frontiers in Physiology | www.frontiersin.org 4 April 2021 | Volume 12 | Article 659834
fphys-12-659834 April 9, 2021 Time: 11:55 # 5
Bowden Davies et al. Physical (In)activity and Endothelial (Dys)function
A B C
D E F
FIGURE 1 | Physical activity data for individuals at baseline, following step-reduction and resuming activity, including daily average step count (A), TEE (B), daily
waking sedentary time (<1.5 METS) (C), daily light activity (1.5–3 METS) (D), daily moderate activity (3–6 METS) (E), and daily vigorous activity (>6 METS) (F). Data
are presented as mean ± SD; *P < 0.05 main effect of time.
A B C
D E F
FIGURE 2 | Data for individuals at baseline, following step- reduction and resumption of activity. Flow mediated dilation; FMD (A), V̇O2 peak (B), lower limb lean
mass (C), total body fat (D), liver fat; IHCL (E), and whole-body IS (F). Data are presented as mean ± SD; *P < 0.05 main effect of time.
TABLE 2 | Data of the brachial artery vascular function at baseline, following 14 days of physical inactivity and 14 days resumption to habitual activity.
Baseline Step-reduction Resuming activity P d
Flow-mediated dilation; FMD (%) 8.1 (6.8, 9.3) 6.2 (5.2, 7.3) 7.6 (6.5, 8.8) 0.04 0.117
Baseline diameter (mm) 0.36 (0.34, 0.39) 0.34 (0.32, 0.37) 0.36 (0.33, 0.38) 0.07 0.102
Peak diameter (mm) 0.39 (0.36, 0.42) 0.37 (0.35, 0.40) 0.39 (0.36, 0.41) 0.07 0.106
Shear rate AUC (s−1 × 103) 25331 (22862, 32089) 26954 (22862, 31047) 26478 (20757, 32199) 0.86 0.005
Time to peak (s) 58.5 (47.2, 69.8) 64.1 (56.1, 72.2) 65.3 (56.4, 47.1) 0.41 0.031
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Significant outcomes were also found for absolute V̇O2 which
decreased by 0.2 L/min (0.1, 0.3; P = 0.013) and V̇O2 peak relative
to lean body mass which decreased by 3.5 kg/ml/min (0.3, 6.7;
P = 0.029).
Lean Body Mass
Following step-reduction, lower limb lean mass decreased by
0.2 kg (0.2, 0.4; P = 0.029; Figure 2C), while upper limb lean mass
and total body lean mass did not significantly change (P > 0.05).
Liver and Body Fat
Following step-reduction, IHCL (liver fat) increased by 0.2% (0.1,
0.5; P = 0.022; Figure 2E), total body fat increased by 0.5% (0.1,
0.9; P = 0.014; Figure 2D) and android fat increased by 0.9%
(0.1, 1.6; P = 0.017). However, changes in gynoid fat fell short
of statistical significance (P = 0.078) and no significant difference
was observed in IMCL (skeletal muscle lipid) (P = 0.199).
Metabolic Markers
Following 14 days of step-reduction whole-body IS (Matsuda
index) had decreased by 0.6 (0.1, 1.2; P = 0.020; Figure 2F).
Circulating triglycerides increased by 0.2 mmol/L (0.1, 0.3;
P = 0.016) following step-reduction. Total cholesterol, HDL, LDL,
and HOMA-IR were not significantly altered by the intervention
(P > 0.05).
Return to Normal Activity
All clinical, biochemical, body composition cardiorespiratory
fitness, and cardiovascular measures returned to levels
comparable with baseline after 14 days resumption of habitual
physical activity.
DISCUSSION
The results confirm our hypothesis that endothelial function
becomes compromised (i.e., FMD is reduced) with a short-term
reduction in physical activity and a concomitant increase in
sedentary behavior. In parallel, step-reduction caused a decline
in cardiorespiratory fitness and insulin sensitivity and promoted
fat deposition (increased total body fat, waist circumference,
and liver fat). Importantly, following resumption of normal
activity, all changes were restored to baseline, in agreement with
our previous metabolic findings during the same intervention
(Bowden Davies et al., 2018). The observed changes in FMD are
striking; a reduction of 1.8%, statistically controlling for baseline
artery diameter, following step-reduction can be put into context
by considering meta-analysis data: a 1% increase in FMD is
associated with a relative risk reduction in CVD of 0.87 (Inaba
et al., 2010). FMD returned to normal on resumption of activity.
These data highlight the profound modulation physical activity
may have on endothelial function, with potentially prognostic
relevance for incident CVD.
Step-reduction research is in its infancy, although it already
offers much mechanistic insight into the associated metabolic
and musculoskeletal effects (recently reviewed Bowden Davies
et al., 2019). The decline in cardiorespiratory fitness in this study
confirms whole-body cardiovascular decompensation associated
with inactivity, which may relate to the decompensation in
endothelial function. The results from a variety of studies
examining changes in vascular function with different durations
and ‘doses’ of step reduction have yielded contrasting findings.
An acute bout (4 h) of sedentary behavior has been shown to
reduce superficial femoral artery blood flow, but not FMD (Carter
et al., 2019). Whereas, FMD is worsened in other studies of
3 h to 5 days of reduced physical activity (Boyle et al., 2013;
Restaino et al., 2016). Countermeasures have also been examined;
local heating, can abolish the impairment of endothelial function
associated with an acute episode of sedentary behavior (Restaino
et al., 2016) or with reduced daily steps (Teixeira et al., 2017)
by attenuating the reduction in limb blood-flow, and thus also
in shear stress. Our study is the first to investigate endothelial
function with a longer-term intervention with inactivity (∼2,000
steps/day). The present data demonstrates the ‘downstream’
vascular effects of alterations in physical activity; we speculate
mechanisms may include a reduction in shear stress, a down
regulation of nitric oxide (NO) bioavailability and likely minor
structural vascular alterations (Kim et al., 2006). A proposed
schematic is shown in Figure 3.
As a result of physical inactivity, we observed small but
significant changes in metabolic profiles and body composition
that would predispose individuals to the development of
metabolic syndrome and/or type 2 diabetes: a decrease in
insulin sensitivity, increase in plasma triglycerides (0.2 mmol/L),
loss of (lower limb) lean body mass and deposition of
total body and liver fat (0.2%). In terms of the twin cycle
hypothesis (Taylor, 2008), it has been suggested that insulin
sensitivity and liver fat mediate the association of physical
activity with glycemic control (Koivula et al., 2020). Our
previous study showed that changes in insulin sensitivity
were specific to skeletal muscle (Bowden Davies et al., 2018).
It therefore seems plausible the primary effect of reduced
physical activity is peripheral insulin resistance, with secondary
consequences in the liver including attenuated suppression of
hepatic gluconeogenesis, and over-production of lipoproteins.
Our intervention did not induce a significant change in IMCL
(i.e., skeletal muscle lipid). However, recent findings employing
unilateral limb suspension as a model of inactivity, caused
a decrease in mitochondrial oxidative capacity accompanied
by increased IMCL purporting a role for lipotoxicity-induced
mitochondrial dysfunction in the development of insulin
resistance (Bilet et al., 2020).
The worsened metabolic profile from reduced physical
activity has also been associated with increased CVD risk and
early atherosclerosis (Gastaldelli et al., 2009). Furthermore,
non-alcoholic fatty liver disease (NAFLD) is linked with the
pathogenesis of atherosclerosis (Brouwers et al., 2019). Elevated
circulating triglycerides, reported to be causal in the pathogenesis
of coronary artery disease (Do et al., 2013), combined with
endothelial dysfunction, trigger low-grade inflammation which
can over time cause vulnerable plaque formation. Indeed, the
vascular and metabolic effects demonstrated here may provide a
mechanistic basis whereby physical inactivity can cause or at least
accelerate disease progression.
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FIGURE 3 | Mechanisms of short-term (14 days) physical inactivity and its role in the development of cardio-metabolic complications. Low levels of physical activity
are associated with reduced shear stress; brachial artery endothelial function is compromised as a consequence of 14 days inactivity, as such NO mediated
endothelium vasodilation is worsened. Low levels of physical activity alter insulin and AMPK signaling pathways in skeletal muscle and reduce GLUT4 translocation
and glucose uptake. Skeletal muscle insulin resistance means additional glucose substrate for de novo lipogenesis in adipose tissue and the liver with expansion of
adipose tissue and intra-hepatic lipid. Systemic insulin resistance, higher levels of circulating NEFA and TG are observed. Vascular insulin resistance may also
contribute to peripheral insulin resistance in part due to reduced blood flow. In contrast, in habitually active individuals shear stress mediates endothelial-mediated
vasodilatation (which together with intact skeletal muscle AMPK and insulin signaling) contributes to preserved peripheral insulin resistance. This figure is adapted
from Bowden Davies et al. (2019) with full permissions from the authors and publisher.
Individuals at high risk of (or already suffering from)
cardio-metabolic disease, and older adults, may be more
susceptible to the deleterious effects of inactivity. Understanding
the mechanistic basis of this pathophysiology may aid
implementation of non-pharmacological interventions, as
well as help identify novel therapeutic molecular targets as
‘exercise-mimetics.’ The degree of decompensation observed
after periods of inactivity in individuals with poorer baseline
metabolic/musculoskeletal health or lower baseline physically
activity may indeed be less effective; further research is needed
to address this possibility. Such studies of course raise serious
ethical questions: while young adults return rapidly to baseline
health following resumption of normal activity, recovery is more
prolonged in older, pre-diabetic adults (McGlory et al., 2017).
It might be suggested that the changes could be attributed to
reduced total energy expenditure in the absence of any dietary
alterations. However, as Taylor suggests (Taylor, 2008), the
twin cycle mechanism operates with chronic positive energy
balance; here we observe marked changes to physiology that
are short-term effects of physical inactivity as opposed to
positive energy balance.
In this first study to examine the endothelial response to
short-term changes to physical activity we acknowledge some
limitations. For example, its wider validity to other cohorts (e.g.,
older adults and those at risk of/with disease) and those with
lower baseline level of physical activity (i.e., <10,000 steps/day).
We acknowledge the absence of a control group: inclusion
of an additional group of participants who persist with their
habitual physical activity, having the same serial measurements,
would have provided useful insight; a randomized cross-over
design would be optimal. It may be that a longer duration of
step-reduction might have revealed more effects. Key strengths of
the study include complete objective monitoring of participants
(confirming protocol adherence) with comprehensive and
validated methods of metabolic and body composition
assessment that provide a whole-body, integrative physiological
assessment of the impact of reduced physical activity.
Furthermore, this method of assessing endothelial function is
considered the gold standard in the most recent expert consensus
and evidence-based recommendations (Thijssen et al., 2019).
In summary, in young, non-obese adults, even short-term
physical inactivity and increased sedentary behavior induces
significant decline in endothelial function, a surrogate marker for
incident CVD. In line with previous observations, a decline in
cardiorespiratory fitness was accompanied by whole body insulin
resistance and central and liver fat deposition. All changes were
entirely reversible with resumption of normal levels of physical
activity. Targeting sedentary behavior and promoting physical
activity has clear implications to addressing the burden of type
2 diabetes and CVD.
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